Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Breastfeeding is perfectly acceptable in mothers that are affected by gastroenteritis, as long as their clinical condition permits it (Lawrence 2016 p.776-791, Appendix D: Precautions and Breastfeeding Recommendations for Selected Maternal Infections).
Medication used in the few diarrhea ailments that require specific pharmacological treatment are compatible with breastfeeding.
The germs, viruses or bacteria that cause gastroentercolitis are not transmitted by milk.
Standard preventive measures (hand washing, use of gloves, meticulous hygiene) and for contact (use of clothes to avoid direct contact with cutaneous areas that may be contaminated) are required to prevent the transmission from mother to child (Lawrence 2016 p.408 -409).
Breast milk contains immunoglobulin A (IgA) and other defensive elements (Coppa 2016) against various infectious diseases, so there is a greater risk of transmission if the mother affected by gastroenteritis interrupts breastfeeding.
Numerous studies have shown the benefits of breastfeeding in preventing morbidity and mortality from gastroenteritis and other infections (Frank 2019, Hartman 2019, Westerfield 2018, Ardiç 2018) in communities from poor and developing countries (Turin 2014), as well as in industrialized countries (Paricio 2006).
Infants with norovirus gastroenteritis, whose mothers had positive serology and a level of anti-norovirus IgA in breast milk, had reduced diarrhea symptoms (Labayo 2021).